14-day Premium Trial Subscription Try For FreeTry Free

ARCA biopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.74. In total, the insiders bought 6 411 926 and sold 10 357 752 ABIO shares in the last 100 trades.

Insider Power

(Last 100 transactions)
90.74
Buy 6 411 926 Shares
Sell 10 357 752 Shares

Historical Insider Trades

Date Type Action Person Amount
Aug 29, 2024 Stock option (right to buy) Sell Ma-weaver Jacob 6 000
Aug 29, 2024 Stock option (right to buy) Sell Ma-weaver Jacob 6 000
Aug 29, 2024 Stock option (right to buy) Sell Ma-weaver Jacob 12 000
Aug 16, 2024 Common Stock Buy Janus Henderson Group Plc 428
Aug 16, 2024 Common Stock Buy Janus Henderson Group Plc 5 390
Jul 25, 2024 Common Stock Buy Janus Henderson Group Plc 30 227
Jul 24, 2024 Common Stock Buy Janus Henderson Group Plc 7 056
Jul 24, 2024 Common Stock Buy Janus Henderson Group Plc 17 800
Jul 24, 2024 Common Stock Buy Janus Henderson Group Plc 165 000
Jul 11, 2024 Common Stock Buy Janus Henderson Group Plc 94 537
Jul 10, 2024 Common Stock Buy Janus Henderson Group Plc 21 963
Jul 10, 2024 Common Stock Buy Janus Henderson Group Plc 33 500
Jul 09, 2024 Common Stock Buy Janus Henderson Group Plc 16 917
Jul 08, 2024 Common Stock Buy Janus Henderson Group Plc 17 600
Jul 08, 2024 Common Stock Buy Janus Henderson Group Plc 29 892
Jul 05, 2024 Common Stock Buy Janus Henderson Group Plc 5 000
Jul 05, 2024 Common Stock Buy Janus Henderson Group Plc 23 326
Jul 03, 2024 Common Stock Buy Janus Henderson Group Plc 166 042
Jul 02, 2024 Common Stock Buy Janus Henderson Group Plc 0
Jan 30, 2024 Stock option (right to buy) Buy Ma-weaver Jacob 6 000
Jan 30, 2024 Stock Option (right to buy) Buy Hove Anders D 6 000
Jan 30, 2024 Stock Option (right to buy) Buy Mitchell Daniel J 6 000
Jan 30, 2024 Stock Option (right to buy) Buy Flynn James P 6 000
Jan 30, 2024 Stock Option (right to buy) Buy Conway Robert E 6 000
Jan 30, 2024 Stock Option (right to buy) Buy Grais Linda 6 000
Click to get the best stock tips daily for free!
ABOUT ARCA BIOPHARMA
ARCA biopharma
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase...
GOLDEN STAR
Ticker Change Signal Date
WM
$207.93
0.558% Oct 01
VET
$9.77
7.06% Sep 30
FSK
$19.73
1.57% Sep 30
XOM
$115.82
5.84% Sep 27
HES
$133.61
5.43% Sep 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE